| |
|
|
|
Rigel Pharmaceuticals Inc.  
|
|
2.37 0.05 (0.02%) |
04-18 16:00 |
|
Open: |
2.32 |
Pre close: |
2.32 |
Target:
|
2.93 
|
|
High: |
2.39 |
Low: |
2.225 |
Resistance:
|
2.51
2.68
|
|
Volume: |
2,057,631 |
Market Cap: |
396M |
Support:
|
2.22
1.85
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.41
|
MACD |
MACD(12,26):
|
0.00 |
|
MA(20): |
2.45 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
2.39 |
Stochastic Oscillator |
%K(14,3):
|
30.55  |
|
MA(250): |
2.86 |
%D(3): |
34.30 |
|
Average Volume(K) |
3-Month: |
168773
|
52-Week |
High:
|
4.12 |
|
10-Days: |
129360 |
Low: |
1.96 |
|
RSI |
RSI(14):
|
47.35 |
Change(%): |
-38.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.450 |
Return on Equity (ttm) |
-68.3 |
Shares Out. (M) |
167.17 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-55.7 |
Shares Float (M) |
166.50 |
|
EPS Est. Next Year |
-0.430 |
PEG Ratio |
-0.09 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
153.90 |
|
Forward EPS |
-0.470 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.850 |
EBITDA (p.s.) |
0.000 |
P/E |
-5.27 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.62 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-58.83 |
P/S |
1414974592.00 |
|
Operating Margin |
-163.30 |
Levered Free Cash Flow
(M) |
-35.61 |
P/CF |
-6.73 |
|
|
|
|
|
|
